Is there an Indian version of bosutinib? How much does a bottle cost?

Bosutinib (Bosutinib) has an Indian version. The Indian version of bosutinib is a generic drug whose pharmaceutical ingredients are basically the same as those of the original drug, but the price is usually much lower than the original drug, making treatment more affordable for more patients. Specific prices vary by manufacturer, specifications and sales channels.

Bosutinib is used in adults to treat a type of blood cancer called Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Bosutinib is usually used after other treatments have failed. Bosutinib may also be used for purposes not listed in this Medication Guide. Bosutinib provides an additional treatment option for patients with Bcr-Abl mutations. The recommended dose of bosutinib is 500 mg taken orally once daily with food. Physicians should advise patients to take bosutinib with a high-fat meal, as this will improve absorption and tolerability, and to continue treatment until intolerance develops or disease progression occurs. For patients without grade 3 or higher adverse reactions who do not experience a complete hematologic response or CCyR at weeks 8 or 12, a dose increase to 600 mg daily should be considered.

The originator drug of bosutinib is not marketed in the country, so it cannot be included in medical insurance. Currently, the original drugs sold overseas include Turkish version and European version. The price of the Turkish version may be more than RMB 2,000 per box of 500mg*28, and the price of the European version may be more than RMB 30,000 (the price may fluctuate due to the exchange rate). Currently, the generic version of bosutinib sold overseas, with specifications of 500mg*30, may cost more than 2,000 yuan per box (the price may fluctuate due to exchange rates), which is relatively cheap.